| 7985430 |
Levine et al. |
The present invention relates to an adhesive solid dosage form containing a mixture of herbal extracts as the active ingredient, suitable particularly for the treatment of mucosal lesions. |
[125] |
| 7153845 |
Levine et al. |
The present invention relates to progressive hydration tablets for adhesion to the wall of a body cavity for the sustained release of active ingredients. |
[126] |
| 6063404 |
Timpe et al. |
This invention relates to a bioadhesive tablet containing at least one bioadhesive adjuvant and at least one lubricant, with at least one surface of said tablet comprising concentric or parallel, straight and/or curved depressions, and to a method for producing said bioadhesive tablets. |
[127] |
| 6916485 |
Aiache et al. |
The present invention relates to novel prolonged release bioadhesive therapeutic systems for treating local mucosal infections or the mucitis and candidiasis type. |
[128] |
| 20020044964 |
Bologna et al. |
The present invention relates to progressive hydration tablets for adhesion to the wall of a body cavity [oral, vaginal] for the sustained release of active ingredients without premature degradation of the active ingredients. |
[129] |
| 6210699 |
Acharya et al. |
This invention relates to an improved dosage form which can easily adhere to the inner buccal cavity and sustain transmucosal release of drugs, odorants or any other ingredients, wherein said dosage form is a tablet. |
[130] |
| 5330761 |
Baichwal et al. |
The present invention relates to a controlled release bioadhesive tabletwhich includes a locally active agent, a heterodisperse gum matrix, and pharmaceutically acceptable diluents. |
[131] |
| 6242004 |
Rault et al. |
The invention relates to bioadhesive compounds in the form of multilayers, and having at least one bioadhesive layer with the total charge of bioadhesive material; the bioadhesive layer being directly compressible during the production of the tablet. |
[132] |
| 5091184 |
Khanna et al. |
Objective of the present invention: to provide an improved dosage form for the administration of baclofen, in the form of an adhesive tablet, to the mucosa in the oral cavity that permits uniform administration at constant intervals. |
[133] |
